Tag Archives: outlook

Intel Data Centre Results, Margin Outlook Disappoint

Intel Corp’s fast-growing data centre business missed Wall Street targets on Thursday as the world’s second-largest chipmaker faced stiff rivalry from Advanced Micro Devices, and it again delayed the release of its next-generation chips until the end of 2019. The company’s shares fell almost 5 percent in extended trading. Sales to data centres that power mobile and web apps, which bring more ... Read More »

Crisil Ups Outlook On 18 PSU Banks After Capital Infusion Plan

The government would pump Rs. 88,139 crore into 20 PSU banks before end-March (Representational image) Mumbai: Rating agency Crisil on Friday revised upwards the outlook on 18 state-run banks to ‘stable’ from ‘negative’ and also reaffirmed their ratings following the announcement of capital infusion worth Rs. 88,139 crore by the government. The agency said move will strengthen the balance sheets ... Read More »

Microsoft Outlook for Mac to Add Google Calendar, Contacts Support

HIGHLIGHTS This support is only available for Insider members for now The Outlook for mac update also brings Focused Inbox feature It also improves on its package delivery and ticket reservations feature Microsoft is updating its Outlook mail app for Mac users with many features that would make Google account users happy. It is bringing support for Google Calendar and ... Read More »

Worries and uncertainty cloud outlook for digital privacy under President Trump

Some legal experts are worried Trump could abuse the NSA’s surveillance powers, but we just don’t know Donald Trump speaking to supporters at an immigration policy speech at the Phoenix Convention Center in Phoenix, Arizona, on August 31, 2016. Credit: Gage Skidmore 6COMMENTS Michael Kan IDG News Service Nov 9, 2016 4:53 PM When President-elect Donald Trump officially takes office, ... Read More »

Sarepta inventory nuked by FDA outlook

res of Sarepta Therapeutics nearly halved on Thursday after the meals and Drug management maintained its “poor” outlook on the employer‘s drug for an extraordinary muscle-wasting ailment. Sarepta stock closed down more than forty four percentage. Sarepta is seeking out extended acclaim for eteplirsen to treat a subset of patients with Duchenne muscular dystrophy (DMD). FDA workforce reviewers on Thursday ... Read More »